Marco Giovannini

13.8k total citations · 1 hit paper
221 papers, 8.6k citations indexed

About

Marco Giovannini is a scholar working on Neurology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Marco Giovannini has authored 221 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Neurology, 60 papers in Pulmonary and Respiratory Medicine and 44 papers in Molecular Biology. Recurrent topics in Marco Giovannini's work include Neurofibromatosis and Schwannoma Cases (58 papers), Sarcoma Diagnosis and Treatment (26 papers) and Neuroblastoma Research and Treatments (18 papers). Marco Giovannini is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (58 papers), Sarcoma Diagnosis and Treatment (26 papers) and Neuroblastoma Research and Treatments (18 papers). Marco Giovannini collaborates with scholars based in United States, Italy and France. Marco Giovannini's co-authors include Michiko Niwa‐Kawakita, Andrea I. McClatchey, Fabrice Chareyre, Michel Kalamarides, Ichiko Saotome, Marcello Curto, A. Berns, Dominique Lallemand, David H. Gutmann and Vincent Abramowski and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Marco Giovannini

216 papers receiving 8.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Merlin/NF2 Tumor Suppressor Functions through the YAP Oncoprotein to Regulate Tissue Homeostasis in Mammals

2010 612 citations Marco Giovannini et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marco Giovannini United States	50	3.3k	2.3k	2.0k	1.4k	1.4k	221	8.6k
Dennis K. Burns United States	50	4.2k 1.3×	2.0k 0.9×	812 0.4×	1.8k 1.3×	1.9k 1.4×	145	11.0k
Marc K. Rosenblum United States	67	3.9k 1.2×	4.8k 2.1×	462 0.2×	2.3k 1.6×	2.3k 1.7×	254	14.8k
Lydia Sorokin Germany	67	5.5k 1.7×	618 0.3×	2.5k 1.3×	1.9k 1.3×	646 0.5×	174	14.0k
Jay L. Degen United States	66	3.8k 1.2×	514 0.2×	832 0.4×	2.0k 1.4×	1.7k 1.3×	151	15.3k
Hans E. Grossniklaus United States	56	3.5k 1.1×	973 0.4×	505 0.3×	2.2k 1.5×	1.2k 0.9×	485	13.3k
Masahiko Kuroda Japan	47	7.1k 2.2×	426 0.2×	1.8k 0.9×	2.3k 1.6×	1.2k 0.8×	228	12.2k
Gianni Bussolati Italy	54	2.3k 0.7×	564 0.2×	544 0.3×	2.6k 1.8×	1.5k 1.1×	253	9.0k
R. Moll Germany	46	3.1k 1.0×	423 0.2×	2.9k 1.4×	2.0k 1.4×	966 0.7×	153	8.7k
Fausto J. Rodríguez United States	47	2.3k 0.7×	2.2k 1.0×	320 0.2×	810 0.6×	1.5k 1.1×	214	7.5k
Jag Bhawan United States	42	1.2k 0.4×	510 0.2×	1.2k 0.6×	1.6k 1.1×	1.0k 0.7×	261	6.6k

Countries citing papers authored by Marco Giovannini

Since Specialization

Citations

This map shows the geographic impact of Marco Giovannini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Giovannini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Giovannini more than expected).

Fields of papers citing papers by Marco Giovannini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Giovannini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Giovannini. The network helps show where Marco Giovannini may publish in the future.

Co-authorship network of co-authors of Marco Giovannini

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Giovannini. A scholar is included among the top collaborators of Marco Giovannini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Giovannini. Marco Giovannini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Catalano, Gianfranco, et al.. (2025). Venetoclax and new BCL-2 inhibitors in acute myeloid leukemia. Expert Opinion on Pharmacotherapy. 26(16). 1725–1739.

Niscola, Pasquale, Valentina Gianfelici, Gianfranco Catalano, et al.. (2024). Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies. Current Oncology. 31(11). 6632–6658. 5 indexed citations

Jordan, Justin T., Roberta L. Beauchamp, Alona Muzikansky, et al.. (2023). Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2. Neuro-Oncology Advances. 5(1). vdad041–vdad041. 10 indexed citations

Wolf, Jennifer Moriatis, Tobias R. Overbeck, Ji‐Youn Han, et al.. (2020). Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC): results from the phase 2 GEOMETRY mono-1 study. Kölner Universitäts PublikationsServer (Universität zu Köln). 8 indexed citations

Heist, Rebecca S., Edward B. Garon, Daniel S.W. Tan, et al.. (2020). B11 Accurate Detection of METex14 Mutations in Non-Small Cell Lung Cancer (NSCLC) with Comprehensive Genomic Sequencing: Results from the GEOMETRY Mono-1 Study. Journal of Thoracic Oncology. 15(2). S30–S31. 5 indexed citations

Giovannini, Marco, et al.. (2014). Una tumefazione sternale da osteomielite. 17(4). 257.

Tanaka, Karo, Ascia Eskin, Fabrice Chareyre, et al.. (2013). Therapeutic Potential of HSP90 Inhibition for Neurofibromatosis Type 2. Clinical Cancer Research. 19(14). 3856–3870. 28 indexed citations

Giovannini, Marco, et al.. (2012). Suppression of spurious modes via dummy electrodes and 2% frequency shift via cavity size selection for 1 GHz AlN MEMS contour-mode resonators. 1–5. 4 indexed citations

Robanus-Maandag, Els C., Cathy A.J. Bosch, Saeid Amini‐Nik, et al.. (2011). Familial Adenomatous Polyposis-Associated Desmoids Display Significantly More Genetic Changes than Sporadic Desmoids. PLoS ONE. 6(9). e24354–e24354. 22 indexed citations

10.

Jean, Didier, Emilie Thomas, Élodie Manié, et al.. (2011). Syntenic Relationships between Genomic Profiles of Fiber-Induced Murine and Human Malignant Mesothelioma. American Journal Of Pathology. 178(2). 881–894. 36 indexed citations

11.

Giovannini, Marco, Ferdinando Raimondi, Giuseppe d’Annunzio, et al.. (2011). A novel hepatocyte nuclear factor-1β (MODY 5) gene mutation in a Romanian boy with pancreatic calcifications, renal and hepatic dysfunction.. PubMed. 55–60. 3 indexed citations

12.

Goutagny, Stéphane, Hong Yang, Jessica Zucman‐Rossi, et al.. (2010). Genomic Profiling Reveals Alternative Genetic Pathways of Meningioma Malignant Progression Dependent on the Underlying NF2 Status. Clinical Cancer Research. 16(16). 4155–4164. 84 indexed citations

13.

Denisenko, Natalia, Carmen Cifuentes-Díaz, Théano Irinopoulou, et al.. (2008). Tumor Suppressor Schwannomin/Merlin Is Critical for the Organization of Schwann Cell Contacts in Peripheral Nerves. Journal of Neuroscience. 28(42). 10472–10481. 23 indexed citations

14.

Body–Malapel, Mathilde, Sébastien Dharancy, Dominique Berrebi, et al.. (2008). NOD2: a potential target for regulating liver injury. Laboratory Investigation. 88(3). 318–327. 36 indexed citations

15.

Lallemand, Dominique, Jan Manent, Anne Couvelard, et al.. (2008). Merlin regulates transmembrane receptor accumulation and signaling at the plasma membrane in primary mouse Schwann cells and in human schwannomas. Oncogene. 28(6). 854–865. 98 indexed citations

16.

Morrison, Helen, Tobias Sperka, Jan Manent, et al.. (2007). Merlin/Neurofibromatosis Type 2 Suppresses Growth by Inhibiting the Activation of Ras and Rac. Cancer Research. 67(2). 520–527. 170 indexed citations

17.

Crone, Steven A., et al.. (2003). Colonic Epithelial Expression of ErbB2 Is Required for Postnatal Maintenance of the Enteric Nervous System. Neuron. 37(1). 29–40. 55 indexed citations

18.

Giovannini, Marco, Jaclyn A. Biegel, Massimo Serra, et al.. (1994). EWS-erg and EWS-Fli1 fusion transcripts in Ewing's sarcoma and primitive neuroectodermal tumors with variant translocations.. Journal of Clinical Investigation. 94(2). 489–496. 116 indexed citations

19.

Re, Maria Carla, Giorgio Zauli, G. Furlini, et al.. (1992). GM-CSF production by CD4+ T-lymphocytes is selectively impaired during the course of HIV-1 infection. A possible indication of a preferential lesion of a specific subset of peripheral blood CD4+ T-lymphocytes.. PubMed. 15(3). 265–70. 5 indexed citations

20.

Bagnara, Gian Paolo, Giorgio Zauli, Marco Giovannini, et al.. (1990). Early loss of circulating hemopoietic progenitors in HIV-1-infected subjects.. PubMed. 18(5). 426–30. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact